MS

Marten Steen

Managing Partner, HealthCap

Stockholm County

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Pharmaceutical Industry
Life Sciences
Biotechnology
Strategy
Venture Capital

Education

Investments

ADCendo

Series A

Total Funding: $110M

Priothera

Series A

Total Funding: $35M

Precirix

Series A

Total Funding: $130M

Wilson Therapeutics

Series B

Total Funding: $40M

Ultragenyx Pharmaceutical

Series A

Total Funding: $120M

FerroKin Biosciences

Series B

Total Funding: $12M

Immune Targeting Systems

Series A

Total Funding: $20M

Work Experience

H
HealthCap

2010

  • Managing Partner

    2010

HT
Hemab Therapeutics

2021

  • Board Member

    2021

AB
Aro Biotherapeutics

2021

  • Board Member

    2021

MT
Mahzi Therapeutics

2020

  • Board Member

    2020

Priothera

2020

  • Board Member

    2020

VT
Vivet Therapeutics

2018

  • Board Member

    2018

P
Precirix

2018

  • Board Member

    2018

A
Adcendo

2021 - 2022

  • Board Member

    2021 - 2022

Strongbridge Biopharma plc

2014 - 2021

  • Board Member

    2014 - 2021

    Acquired by Xeris

Rainier Therapeutics (Previously BioClin Tx)

2014 - 2020

  • Board Member

    2014 - 2020

    Acquired by Fusion Pharmaceuticals